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Abstract
Background: Given the double jeopardy of global increases in rates of obesity and climate change, it is
increasingly important to recognise the dangers posed to diabetic patients during periods of extreme
weather. We aimed to characterise the associations between ambient temperature and general medical
practitioner consultations made by a cohort of type-2 diabetic patients. Evidence on the effects of
temperature variation in the primary care setting is currently limited.
Methods: Case-crossover analysis of 4,474,943 consultations in England during 2012–2014, linked to localised
temperature at place of residence for each patient. Conditional logistic regression was used to assess associations
between each temperature-related consultation and control days matched on day-of-week.
Results: There was an increased odds of seeking medical consultation associated with high temperatures: Odds ratio
(OR) = 1.097 (95% confidence interval = 1.041, 1.156) per 1 °C increase above 22 °C. Odds during low temperatures
below 0 °C were also significantly raised: OR = 1.024 (1.019, 1.030). Heat-related consultations were particularly high
among diabetics with cardiovascular comorbidities: OR = 1.171 (1.031, 1.331), but there was no heightened risk with
renal failure or neuropathy comorbidities. Surprisingly, lower odds of heat-related consultation were associated with
the use of diuretics, anticholinergics, antipsychotics or antidepressants compared to non-use, especially among those
with cardiovascular comorbidities, although differences were not statistically significant.
Conclusions: Type-2 diabetic patients are at increased odds of medical consultation during days of temperature
extremes, especially during hot weather. The common assumption that certain medication use heightens the risk of
heat illness was not borne-out by our study on diabetics in a primary care setting and such advice may need to be
reconsidered in heat protection plans.
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Background
It is commonly recognised that temperature extremes
raise the risk of mortality and morbidity from cardio-
respiratory conditions, and diabetic patients are also at
increased risk. For example, in the US diabetics were re-
ported to have a 17% higher risk of dying on hot days
compared to other subjects, which was greater than for
any other disease considered [1]. This is probably due to
compromised heat dissipation among diabetics which
increases the risk of heat-related illness [2, 3]. Further-
more, the condition can also lead to impaired vascular
response similar to that commonly observed among the
elderly during cold weather conditions [4]. The global
prevalence of diabetes among adults rose from 4.7% in
1980 to 8.5% (422 million people) in 2014, of which
about 90% have type-2 diabetes which is largely caused
by excess body weight and a sedentary lifestyle [5]. The
World Health Organization projects that diabetes will be
the 7th leading cause of death globally by 2030 [6].
Given the double jeopardy of global increases in obes-
ity rates and global climate change, it is increasingly
important to recognise the dangers posed to diabetic
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patients during periods of extreme weather, especially
high temperatures. Although such individuals may be
identified as high-risk in the public health heat-
protection plans of many countries, the unique chal-
lenges faced by diabetics are rarely addressed. For
example, since type-2 diabetes is increasingly diagnosed
in younger adults and children due to rising obesity rates
in these groups, impacts may not be restricted to older
age-groups traditionally at risk during hot and cold wea-
ther. Comorbidities commonly associated with diabetes,
such as chronic kidney disease, cardiovascular disease
and neurologic sequelae, may confer additional risks
during climate extremes [7]. Furthermore, medications
frequently prescribed to diabetics such as diuretics and
salicylates can adversely affect thermoregulation, and the
use of other common drugs such as anticholinergics, an-
tidepressants and antipsychotics that interfere with the
normal sweating process may also intensify heat-related
risk in this sensitive group [7]. Although mechanisms
have been postulated by which medications may
heighten heat risk, there is little epidemiological evi-
dence to support singling-out specific drug-types, nor
the extent to which any increased risk is attributable to
the drug or to the underlying disease it is being used to
treat [8].
Evidence on the effects of heat and cold exposure in
the primary care setting are limited compared to other
morbidity outcomes such as hospitalisations, even
though the number of patient contacts involved is
greater and intervention at this stage has the potential to
prevent heat-related illness deteriorating, resulting in
hospitalisation or death. Use of general medical practi-
tioner (GP) patient data also opens up the possibility of
assessing important comorbidities and information on
medication use which may not be available with other
databases.
Another limitation of much previous work is the
characterization of ambient temperature exposure based
on measurements recorded at fixed monitoring stations,
which may not be a good indicator of personal exposure.
Gridded climate datasets based on the interpolation of
observed measurements can determine weather condi-
tions at high spatial resolution and so have the potential
to overcome this problem [9].
In this study we linked the place of residence of a large
cohort of type-2 diabetic patients registered on GP data-
bases across England to gridded climate data in order to
characterise temperature-related consultations among
these high-risk patients, and to assess possible modifica-
tion of effects by patient characteristics, comorbidities
and medication use. This information has the potential
to identify and provide support for those diabetic pa-
tients and their healthcare providers most at risk during
climate extremes.
Methods
Health data
General practice data were obtained from the Research-
One database developed by TPP (The Phoenix Partner-
ship) in partnership with the University of Leeds and the
UK Government’s Technology Strategy Board (http://
www.researchone.org). The database consists of de-
identified clinical and administrative data drawn from
electronic patient records held on the TPP ‘SystmOne’
clinical system.
Based on the Read Codes (Clinical Terms Version 3)
listed in Additional file 1: Table S1, 191,842 type-2 dia-
betic patients were identified from contributing prac-
tices, which constitutes 5.5% of the total patient cohort.
Information on all appointments made by diabetic pa-
tients, regardless of the reason, during a 3-year period
(2012–2014) was extracted, resulting in 4,474,943
consultations.
Exposure data
Gridded daily mean temperature datasets for the UK at
5 × 5 km resolution, previously created by the Met
Office with financial support from DEFRA, were used to
represent exposure for each patient at the time of
consultation (http://www.metoffice.gov.uk/climatechange/
science/monitoring/ukcp09), with the most recent years
of data being provided via the MEDMI project (https://
www.data-mashup.org.uk/). The datasets are based on ob-
servations from Met Office fixed monitoring stations, with
regression and interpolation methods used to generate
values on a regular grid, taking into account factors such
as latitude and longitude, altitude and terrain shape,
coastal influence, and urban land-use.
Linkage
The patient’s home address at the time of each GP con-
sultation was linked to the gridded temperature dataset.
Grid coordinates were converted into the Eastings and
Northings coordinate system to allow linkage to sector-
level patient postcode data omitting the final 2 letters of
the full postcode for confidentiality reasons (i.e. AB12 3).
Temperature data were rounded to the nearest 0.5 °C in
order to reduce the number of unique combinations of
temperatures that may allow potential re-identification of
individual patients. To further anonymise the dataset, co-
ordinates were randomised whilst still allowing linkage to
the ResearchOne data. This step was necessary to ensure
that the simple knowledge that the Met Office dataset
is arranged in a fixed 180 rows × 290 columns grid
‘map’ could not be used to geographically re-identify
patients. Postcodes for several known geographical
locations were checked manually to ensure the ran-
domisation process had been successful. To maintain
Hajat et al. Environmental Health  (2017) 16:73 Page 2 of 8
maximum confidentiality, the data linkage was con-
ducted in-house by the ResearchOne team.
Analysis
To assess whether temperature exposure influences the
timing of GP consultations by diabetic patients we used
a fixed-stratum case-crossover approach [10]. With this
design, each case is represented by exposure conditions
on the day of consultation, and controls by exposures on
proximate days. Each consultation event was stratified
into a risk-set of 28 days beginning on 1st January 2012.
If patients had more than one consultation per day then
only the first occurrence was analysed since subsequent
consultations are likely to be related.
Conditional logistic regression was then used to assess
the association between each event and its control days
within that risk-set – traditional confounding factors
that are time-invariant over 28-day periods are therefore
implicitly adjusted for. Within each risk-set, the case day
was matched on the day of the week to its control days.
This adjusts for any confounding effect of variation in
consultation numbers by day-of-week, but also removes
possible autocorrelation in the data, i.e. the increased
likelihood of consulting again on subsequent neighbour-
ing days [11]. There were 3 control days for each of the
4,474,943 consultations assessed, with the control days
randomly occurring either before or after the case day,
or a mixture of the two.
The functional form of the relationship between
temperature and odds of GP consultation was first
visualised using natural cubic spline functions with
interior knots at 0, 10 and 20 °C. This indicated lin-
ear increases in the consultation odds both above a
high temperature threshold of 22 °C and below a low
temperature threshold of 0 °C (Additional file 1:
Figure S2). Heat and cold effects were assessed simul-
taneously. In order to capture possible lagged effects
of temperature, and the delays inherent in arranging
a GP appointment, distributed lags up to 7 days fol-
lowing exposure were considered. Lags longer than
7 days were also assessed in relation to cold risk but
none were observed. For events occurring at the start
of each 28-day risk period, data from previous days
were complete since exposure was characterized from
complete time-series of the temperature values before
stratification into non-contiguous periods.
Based on prior hypotheses, assessment was made of
the possible modification of heat effects by patient char-
acteristics (age and sex) and by comorbidities (cardiovas-
cular diseases, respiratory diseases, renal failure, and
neuropathy), with this being determined by each pa-
tient’s consultation history for these conditions. Multiple
comorbidities were not considered simultaneously due
to power limitations. Increased odds due to medication
use was also explored using prescription information for
each patient. Based on current knowledge and where
at least 5% of cases had been prescribed the treat-
ment at any time during the study period, the medi-
cation groups considered were diuretics, salicylates,
anticholinergics, antipsychotics and antidepressants.
The groups were defined using chapters and subchap-
ters of the British National Formulary Classification
system (https://www.bnf.org/). These agents are not
specific to diabetes treatment but may pose a risk by
affecting skin blood flow or sweating [7, 12].
Associations are presented as odds ratios (OR) and
(95% confidence intervals) per 1 °C increase (or de-
crease) in temperature above (or below) thresholds. Ana-
lyses were conducted in STATA14 using the high-power
computing facilities at the London School of Hygiene &
Tropical Medicine.
Results
Figure 1 displays the daily number of consultations over
the 3-year study period. The graph displays a banding of
counts by the day of the week, an Autumn peak each
year, and a trend of increasing counts - likely due to
more practices being recruited onto the database over
time. Overall, 52.6% of the patients were male and 57.5%
were aged 65 years or older. The mean, minimum and
maximum values of daily mean temperature recorded in
contributing grid cells during the 3 year study-period
were 9.2, −10.5, and 27 °C respectively. The mean,
minimum and maximum values recorded specifically on
GP consultation days were 10.3, −8.0, and 25.5 °C
respectively.
The odds of a heat-related GP consultation was
estimated to be OR = 1.097 (95% CI 1.041, 1.156), indi-
cating a 9.7% increase in odds of consultation for every
1 °C increase in temperature above 22 °C summed for
lags 0–7 days from the onset of the temperature rise.
Figure 2 shows the distribution of these effects for the
separate lags. With heat exposure, the majority of this
effect occurred with a 2-day delay: OR = 1.103 (1.080,
1.126). The only other lag that was significantly associ-
ated was on the day of exposure (lag 0): OR = 1.030
(1.009, 1.052). The effect of low temperature was smaller
but still significantly raised: OR = 1.024 (1.019, 1.030) per
1 °C drop in temperature below 0 °C, summed for lags 0–
7 days. Cold risk was significantly raised on lags 0 and
6 days and significantly negative on lags 2 and 3 days.
Given the smaller cold effect, and prior hypotheses,
subgroup analysis is presented for heat risk only.
Table 1 shows heat effects by patient characteristics
and comorbidities. Although interactions did not
reach conventional levels of statistical significance,
patients aged 65 years and above appeared to be at
greater risk than those under 65. Diabetics with
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Fig. 2 Odds ratios of heat- and cold-related consultations per 1 °C temperature change at individual lags
Fig. 1 Time-series of daily number of consultations by diabetic patients in participating practices, 2012–2014
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respiratory problems were also at greater risk, but the
largest differentials were among those with cardiovas-
cular diseases (CVD) who had an almost threefold
odds compared to those without CVD complications.
Surprisingly, there was no additional risk among dia-
betics with renal failure nor those with neuropathy;
indeed, this group had a reduced odds of consulting
on a hot day, although the wide confidence interval
limits interpretation.
Although those with CVD comorbidities were
slightly older than other patients, age was not the ex-
planation for the highly raised odds among diabetics
with CVD complications. The large differentials in
heat risk were present only in the relatively younger
age-groups (Table 2). Among those aged 75+ years,
the odds of heat-related consultation was lower in
those patients with CVD comorbidities.
The odds of consultation on hot days among diabetics
taking salicylates was higher compared to those not tak-
ing them, although only slightly and not significantly so:
1.113 (0.802, 1.546) vs 1.082 (1.026, 1.142) (Table 3).
Contrary to expectations, diuretic use was associated
with reduced odds of a heat-related consultation com-
pared to non-use. The reduction in risk was especially
marked in diabetic patients with CVD comorbidity:
OR = 1.245 (1.003, 1.546) in non-diuretic users vs 1.132
(0.967, 1.326) in users, although this difference was not
statistically significant. A similar pattern was observed
with anticholinergic, antipsychotic and antidepressant
use, with higher odds for non-users with CVD comor-
bidity compared to users, but again no interactions
reached statistical significance.
Discussion
Our results show that diabetic patients are at increased
odds of consulting a GP during days of temperature ex-
tremes, especially during hot weather. Although there
was limited statistical power to detect interactions, dia-
betics with cardiovascular or respiratory comorbidities
had an elevated risk of heat-related GP consultation, but
there was no evidence for a heightened risk among those
with renal failure or neuropathy.
Although some studies have previously reported that
cold is associated with increases in GP visits from re-
spiratory infections in the UK and elsewhere [13, 14], to
date there is very little evidence on the impacts of high
temperatures in the primary care setting, especially
among high risk individuals [15, 16]. Most recently, pri-
mary care visits for asthma by children were shown to
be elevated during summer months in Japan [17]; and in
the UK population a spike in GP activity was observed
during an individual heat-wave period using syndromic
surveillance data [18]. Although the present study did
not consider heat impacts on all primary care consulta-
tions, our results are likely to be specific to diabetic pa-
tients since previous work observed no increased risk of
consultation among other patient groups during the
2013 heat-wave [19]. Our study reveals that heat-related
GP consultations are apparent in high-risk individuals
such as diabetics and are not restricted to extreme heat
periods only. Adverse impacts became apparent at fairly
moderate daily mean temperature values of 22 °C.
We estimated a 9.7% increase in the odds of a GP con-
sultation per 1 °C rise in high temperatures among
type-2 diabetics in England, with the majority of this ef-
fect occurring with a 2 day lag – possibly reflecting the
time taken to access a GP rather than a biological delay
of response to exposure. This increase is greater than
that observed for heat-related emergency hospitalisations
due to diabetes in high-income settings [20–22], but
Table 1 Effect modification of heat-related consultation by
patient characteristics and comorbidities. OR shown for 1 °C
increase above 22 °C and summed for lags 0–7 days
Modifying factor Number of
consultations (%)
OR (95% CI) P-value for
interaction
Sex
Male 2,347,986 (52.6) 1.101 (1.024, 1.185) 0.85
Female 2,113,324 (47.4) 1.090 (1.011, 1.176)
Age-group
< 65 years 1,895,277 (42.5) 1.072 (0.991, 1.158) 0.44
65+ years 2,566,034 (57.5) 1.118 (1.040, 1.201)
CVD
No 3,611,128 (80.9) 1.066 (1.006, 1.129) 0.19
Yes 851,693 (19.1) 1.171 (1.031, 1.331)
Respiratory diseases
No 3,081,816 (69.1) 1.067 (1.002, 1.136) 0.40
Yes 1,381,005 (30.9) 1.122 (1.017, 1.236)
Renal failure
No 4,336,129 (97.2) 1.082 (1.026, 1.142) 0.98
Yes 126,692 (2.8) 1.087 (0.776, 1.522)
Neuropathy
No 4,112,265 (92.2) 1.097 (1.038, 1.159) 0.09
Yes 350,556 (7.9) 0.923 (0.761, 1.120)
Table 2 OR of heat-related consultation, by age-group and CVD
comorbidity
OR (95% CI) per 1 °C increase above 22 °C
Diabetics with no
CVD comorbidity
Diabetics with CVD
comorbidity
Age-group
0–64 years 1.042 (0.958, 1.134) 1.209 (0.987, 1.480)
65–74 years 1.063 (0.950, 1.190) 1.238 (0.977, 1.568)
75+ years 1.109 (0.989, 1.242) 1.054 (0.839, 1.324)
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lower compared to diabetic outpatient visits in a
middle-income country with a tropical climate [23].
Heat-waves in Australia had a much greater impact
on diabetes mortality compared to diabetes hospital
admissions [24]. In our study, the consultation odds
increased to over 17% for diabetics with CVD comor-
bidities. This is consistent with a study from Toronto
where heat-related emergency room visits for CVD
were particularly elevated in patients with diabetes
comorbidity [25]. This indicates that individuals with
either diabetes or CVD problems are likely to be at
increased risk of heat-illness, but especially so for
those with a combination of the two.
Since some medications can interfere with hydration
status, sweat production and electrolyte balance,
drug-use is commonly cited as increasing the risk of
heat-related illness [7]. The classes of drugs consid-
ered to be most problematic are often listed in public
health guidance documentation available as part of
heat protection plans of many countries. However,
such advice tends to be based on hypothesized action
or on experimental evidence conducted in non high-
risk individuals subjected to brief periods of heat
exposure that do not replicate conditions of an urban
heat-wave [8]. The epidemiologic evidence is very
limited – one study observed that use of anti-
psychotic or hypnotic/anxiolytic medications elevated
the risk of heat-related death in people with mental
illnesses [26]. A meta-analysis of 4 studies estimated
that taking psychotropic medications elevated the risk
of death almost twofold during heat-waves [27]. Case
reports have linked both older (chlorpromazine) and
newer (zuclopenthixol, quetiapine) antipsychotic agents,
as well as anticholinergic agents such as benztropine used
to treat the Parkinsonian side-effects of antipsychotics, in
fatal cases of heat-stroke [28, 29].
However, it is unclear in many previous studies how
much of the raised heat-risk was due to the medication use
or to the underlying diseases being treated. We were able
to disentangle the two factors to some extent by assessing
the risk of medication-use in diabetic patients both with
and without comorbidities. We observed no evidence of in-
creased heat-risk due to medication use – indeed odds of
heat-related consultation appeared to be (non-significantly)
lower among diabetics using diuretics, anticholinergics, an-
tipsychotics or antidepressants, especially for those with
CVD comorbidities. This agrees with a comprehensive re-
view of the effects of hyperthermia on pharmacokinetics
which concluded that interactions between heat exposure
and drug therapy are rare and probably limited to special
situations in which local blood flow is greatly enhanced
[30]. In France, serious metabolic adverse drug reactions
(ADRs) among the elderly were less frequent in the hot
summers of 2003 and 2006 compared to other summers,
and other types of ADR showed no variations [31]. One
possibility is that diuretics, anticholinergics, antipsychotic
and antidepressant agents interfere with the perception of
heat and thus alter the threshold for presentation. This
could lead to vulnerable individuals on medication bypass-
ing primary care and presenting directly to hospital, how-
ever a recent study observed that anticholinergic drug-use
in older adults was associated with longer length of stay in
hospital during non heat-wave periods but not during
heat-wave periods [32].
A major strength of the study is the large number of
events analysed. A cohort of 191,842 diabetic patients
was identified from a database of GP practices, resulting
in over 4 million consultations that were matched to
localised temperature conditions around the time of
each visit. The use of gridded temperature data allowed
for reliable characterisation of exposure for each patient
across England, even in remote parts of the country that
Table 3 OR of heat-related consultation, by medication use
OR (95% CI) per 1 °C increase above 22 °C
All diabetics Diabetics with no CVD comorbidity Diabetics with CVD comorbidity
Medication use
Diuretics NO 1.095 (1.013, 1.183) 1.074 (0.988, 1.167) 1.245 (1.003, 1.546)
YES 1.073 (0.999, 1.153) 1.057 (0.975, 1.146) 1.132 (0.967, 1.326)
Salicylates NO 1.082 (1.026, 1.142) 1.066 (1.005, 1.130) 1.169 (1.027, 1.331)
YES 1.113 (0.802, 1.546) 1.071 (0.739, 1.553) 1.147 (0.561, 2.344)
Anticholinergics NO 1.095 (1.037, 1.157) 1.079 (1.015, 1.146) 1.179 (1.033, 1.347)
YES 0.944 (0.781, 1.143)* 0.910 (0.737, 1.123)* 1.057 (0.670, 1.666)
Antipsychotics NO 1.083 (1.025, 1.144) 1.063 (1.001, 1.129) 1.183 (1.038, 1.348)
YES 1.087 (0.889, 1.330) 1.104 (0.891, 1.369) 0.958 (0.532, 1.724)
Antidepressants NO 1.094 (1.025, 1.168) 1.070 (0.996, 1.149) 1.230 (1.048, 1.443)
YES 1.062 (0.971, 1.162) 1.057 (0.957, 1.167) 1.077 (0.872, 1.329)
* p < 0.15 for interaction term
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may be situated some distance from fixed monitoring
stations. Use of gridded data also eliminates missing
values in exposure.
One potential limitation of analysis is that no other
meteorological factors, such as relative humidity, or air
pollutants were assessed as potential confounders or
effect-modifiers. The role of relative humidity has been
shown to be minor in comparison to temperature in the
UK [33], and some have argued that pollution should
not be a confounder in any relationship between
temperature and health [34]. In previous studies on dia-
betes outcomes where results are reported both with
and without air pollution control, the heat effect was not
reduced after pollutant adjustment [21, 35]. One draw-
back with the health data is that, as with other clinical
computing systems, TPP has under-representation in
some parts of the country, in this case the South East
and East of England regions, which may limit generalis-
ability [36]. Furthermore, we were unable to distinguish
between emergency GP consultations from elective ones;
the latter we would not expect to be associated with en-
vironmental triggers, however this should only serve to
introduce noise into our data and bias estimated odds
ratios towards unity. Effects may also have been attenu-
ated by use of broad diagnoses for diabetes (Additional
file 1: Table S1) and comorbidities, and so further work
should consider more specific inclusion codes. We con-
sidered consultations from any cause since heat and cold
exposure can aggravate ill-health from multiple causes,
although such environmental factors are very unlikely to
be indicated in the medical records. Consultations from
specific causes may yield stronger associations, although
lack of power may be a limitation. Also, although medi-
cation use was determined from the prescription infor-
mation detailed for each patient, we did not consider the
frequency of use due to lack of power. Furthermore, it
was impossible to know whether treatment protocols
were adhered to, and so non-adherence may be an alter-
native explanation for the lack of modifying effect
observed with drug use.
Our work highlights the potentially important role that
GPs can play in mitigating heat burdens. As well as heat
impacts being apparent at the primary care level for dia-
betics, GP visits are one of the few social interactions
that vulnerable individuals may experience [37]. When
hot weather is forecast, timely medical advice either dur-
ing routine appointments or during home visits could
minimize the risk of heat stress. Although in the current
study we were unable to follow-up patients to determine
the outcome of each consultation, simple heat protection
advice and management strategies by the GP have the
potential to prevent subsequent heat-related GP visits
and further deterioration possibly resulting in hospitali-
zations and deaths. However, for such actions to be
effective those most vulnerable during hot weather need
to be identifiable and the advice and interventions offered
need to be based on sound evidence. Diabetic patients,
especially those with CVD comorbidities, should be con-
sidered at high-risk and therefore require appropriate
management during temperature extremes, although dia-
betic patients that are physically active and have good
blood glucose control may tolerate heat as well as healthy
individuals [7]. Drug use is often cited as a risk factor for
heat-illness in public health protection plans and treat-
ment regime adjustments during hot weather are com-
monly advocated, however our study suggests that such
advice is likely to be incorrect for diabetic patients in par-
ticular, and this may be the case for other patients too.
Similar assessment of medication effects on risks of heat
exposure in patients with other diseases should be the
subject of future research. The current work could also be
extended by considering the primary reason for GP con-
sultation and whether this varied by temperature, and also
assessment of which mechanisms in diabetic patients with
cardiovascular diseases raise the risk of heat exposure.
More work is also needed on measuring the effectiveness
of specific advice concerning how to minimise heat stress
in the primary care setting.
Conclusions
Consultations with primary care in people with type-2
diabetes are increased during temperature extremes, par-
ticularly on hot days, with suggestive but not definitive
evidence that those with CVD complications are at
higher risk. Public health protection measures should
provide advice to patients with type-2 diabetes and their
healthcare providers about dealing with heat exposure,
and the contribution that GPs could make in helping
identify and manage such patients should be enhanced.
The commonly proffered instruction that certain medi-
cation use heightens the risk of heat-illness was not
borne-out by our study, and such advice may need to be
reconsidered in public health heat protection plans.
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